Company Filing History:
Years Active: 1993-1994
Title: Innovations of John E Airey
Introduction
John E Airey is a notable inventor based in King of Prussia, Pennsylvania. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds with therapeutic applications. With a total of two patents to his name, Airey's work focuses on compounds that exhibit unique properties beneficial for treating various disorders.
Latest Patents
Airey's latest patents include the invention of 2,6-methano-2H-1-benzoxocincarboxylic acids, esters, and amides. These novel compounds possess 5-HT3 antagonist properties, which are crucial for addressing central nervous system issues, antiemetic effects, and gastric prokinetic activities. Importantly, these compounds are designed to avoid significant D2 receptor binding affinity, making them a promising option for therapeutic compositions and methods of treatment for disorders linked to 5-HT3 activity. Additionally, he has developed pharmaceutically useful dibenzofurancarboxamides that also serve as 5-HT3 antagonists, showcasing unique CNS, anti-emetic, and gastric prokinetic activity.
Career Highlights
John E Airey is associated with Rhone-Poulenc Rorer Pharmaceuticals Inc., where he has been instrumental in advancing pharmaceutical research and development. His innovative work has contributed to the understanding and treatment of various medical conditions, particularly those related to serotonin activity in the body.
Collaborations
Airey has collaborated with notable colleagues such as Raymond D Youssefyeh and Matthew R Powers. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.
Conclusion
John E Airey is a distinguished inventor whose work in pharmaceutical innovations has the potential to significantly impact the treatment of disorders related to serotonin activity. His contributions through patents and collaborations highlight the importance of innovation in the medical field.